Product
CRX100
Aliases
CRX100 suspension for infusion
1 clinical trial
10 indications
Indication
Solid TumorIndication
AdultIndication
Triple-Negative Breast CancerIndication
Colorectal CancerIndication
Hepatocellular CarcinomaIndication
OsteosarcomaIndication
Ovarian CancerIndication
Stomach CancerIndication
Lung CancerIndication
MelanomaClinical trial
A Phase 1 Study of the Safety and Efficacy of CRX100 as Monotherapy and in Combination With Pembrolizumab in Advanced Solid MalignanciesStatus: Recruiting, Estimated PCD: 2025-08-01